Feb. 15 -- Thar Process, Inc., a global leader in supercritical fluid technology, announced today the March 2012 opening of its CO2 supercritical toll-processing plant in Pittsburgh, Pennsylvania. The primary focus of this new facility is the nutraceutical and functional food industries, providing customers with natural, solvent-free products that could potentially meet organic market requirements.
With more than 20 years of experience serving the pharmaceutical, food, nutraceutical, chemical, and electronics industries, Thar Process is a single-point-of-access provider of supercritical fluid technology solutions worldwide. It offers services from “concept through commercialization partnership” as well as the design of state-of-the-art pilot and process-scale supercritical plants.
Thar Process integrates its know-how in process and technology, offering contract processing services to deliver solutions in the commercialization of new and well-established products and ingredients. The new facility includes multi-purpose plants for processing solids and liquids that are flexible enough to handle limited production lots, recurrent production runs, and tractor-trailer shipments for high-volume processing.
Thar Process, Inc. won a grant from the Green Building Alliance (GBA) for developing an energy efficient Geothermal Heat Rejection air conditioning system for commercial and residential buildings. This system will be able to take heat directly from inside buildings and expel it to the earth. It will employ carbon dioxide as a heat transfer fluid.
Thar Process’s Alternative Energy Division was awarded a $2 million grant by the National Institute of Standards and Technology (NIST) Alternative Technology Program (ATP) for the development of a novel biodiesel technology that reduces that use of toxic substances and offers a clean, continuous, and economically viable production process.
Thar Process designed, built and commissioned the 2nd GMP plant for a pharmaceutical industry in the United States.
Thar Process built and commissioned the world’s largest industrial-scale supercritical chromatography system, SFC-600. The system is being used in Malaysia to separate and purify micro nutrients from palm oil.
We developed the technology and built the first pilot-plant to offer polymorph screening capabilities under high pressure.
Thar Process built and commissioned the first ever process SFE system in Turkey (2x300L)
Thar Process’s Microsystems Division successfully completed an ATP project that resulted in the development in new technologies in the design of CO2 cooling systems for computers, medical devices, and other microelectronics.
Thar Process built and commissioned an industrial scale counter-current SFE extraction system for purification of tocopherols from deodorized distillate in South Korea.
Thar Process developed the first commercially viable alternative technology for the de-oiling of crude lecithin. We designed, built and commissioned a plant that uses supercritical CO2 rather than acetone in the de-oiling process.
Thar Process’s Microsystems Division was awarded a $2 million grant by the National Institute of Standards and Technology (NIST) Alternative Technology Program (ATP) for groundbreaking R&D in microelectronics technology: “A novel vapor compression system utilizing carbon dioxide”.
We designed and built the first GMP plant in the United States.
FDA Validates Operation of GMP Plant
Built by Thar Process
June 17, 2008
Pittsburgh, PA - The U.S. Food and Drug Administration (FDA) has fully validated a GMP manufacturing process using a supercritical fluid extraction plant designed and built by Thar Process, Inc. With the FDA validation in hand, the U.S.-based pharmaceutical manufacturer has been able to fully implement a unique manufacturing process that capitalizes on the improved efficiency and reduced use of toxic solvents associated with supercritical fluid technology.
This plant is the second GMP certified supercritical fluid extraction plant that Thar Process has designed and built in the US. It is used in a proprietary pharmaceutical manufacturing process. The unique design incorporates an innovative mechanical stirring mechanism into the extraction vessel that is leak free at high pressures and temperatures. This stirring mechanism allows for homogenous mixing with a stable, wobble-free operation.
Contact: Tina Russell, Sales & Marketing